We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Thyngs is a touch-free instant payment platform for businesses and charities. It has around 20 active re-seller partners for new sectors and markets. The company is working with PricewaterhouseCoopers (PwC) as part of its raise programme and actively engaging with several Series A Venture Capitalist (VC) funds intending to raise £4-5 million in late 2021 to scale its business. Thyngs aggregates various payment partners including PayPal, Worldpay, Apple Pay and Google Pay. The company was the cashless donation platform for 210,000 fundraising events for Macmillan's 'World's Biggest Coffee Morning', which raised £27 million in 2019. Many reputed organisations such as Warner Bros, Royal British Legion, Wasabi, National Geographic, and ANZ Bank are working with Thyngs. The company will use the investment to enhance its marketing campaign, bolster its sales team, work on data security and integrations on its platform, and expand the account management team to boost its business.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £329,591
Windsor & Eton Brewery (WAEB) is an award-winning Royal Warrant holding brewery. WAEB brews over 1.4 million pints each year and is on a mission to make beer Windsor's top attraction. WAEB has won over 70 national, international, and regional beer awards. It claims to be a supplier of exclusive bottled beers to the House of Commons, London’s Shakespeare’s Globe, and over 200 pubs, bars, and hotels. The company made over £600,000 of direct sales to consumers through its brewery tap, shop, and home deliveries in 2020. WAEB argues that it is running five successful bars in and near Windsor, serving nearly 7.6 million visitors per year. WAEB created the Windsor beer festival and is a member of the Worshipful Company of Brewers. They intend to use the investment to grow its estate from its existing five venues to twenty by 2026, start with a major new bar in the heart of Windsor, and buy a canning line on-site to ensure fresher beers for its customers.
days to go: Expired investment: £625,931
DeadHappy is a digital-first life insurance provider that aims to disrupt the £3.7 billion life insurance market. The company claims that traditional life insurance is complex, expensive, and inflexible. DeadHappy argues that it can offer customers a cheap, flexible and enjoyable alternative. It has developed a unique pay-as-you-go life insurance product with a rolling 10 year guarantee of cover. A simple sign-up process allows customers to answer only 4 medical questions & obtain cover in under 5 minutes, on-line, via their mobile phone. The company's proprietary Deathwish Platform enables customers to personalise their life insurance by creating ‘Deathwishes’. In 2020, DeadHappy reached 120,000+ total deathwishes and has sold 7,800+ total life insurance policies. The company will use 35% of the investment for company growth, 30% for technology development, 20% for product development, and 15% to build partnerships.
days to go: Expired investment: £2,703,820
Founded in 2012, Holly and Beau is an award-winning kids-wear brand which offers a unique collection of colour changing rainwear. The company sells its products directly through its website and via distributors in the UK, the US, Europe and South Korea. Holly and Beau is in the process of patenting its technology, which will enable it to develop a unique product range of rainwear and skiwear. Moreover, the company has successfully maintained an average revenue growth of 80%-100% YOY.
days to go: Expired investment: £218,570
WiseAlpha is an investment platform that allow its members the opportunity to invest in secured loan investments from some leading UK companies.  
days to go: Expired investment: £579,150
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph